BioNTech SE (BioNTech SE) Days Inventory : 194.76 (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is BioNTech SE Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). BioNTech SE's Average Total Inventories for the three months ended in Dec. 2023 was $417 Mil. BioNTech SE's Cost of Goods Sold for the three months ended in Dec. 2023 was $195 Mil. Hence, BioNTech SE's Days Inventory for the three months ended in Dec. 2023 was 194.76.

The historical rank and industry rank for BioNTech SE's Days Inventory or its related term are showing as below:

BNTX' s Days Inventory Range Over the Past 10 Years
Min: 35.82 Med: 132.93 Max: 252.61
Current: 252.61

During the past 8 years, BioNTech SE's highest Days Inventory was 252.61. The lowest was 35.82. And the median was 132.93.

BNTX's Days Inventory is ranked worse than
60.98% of 651 companies
in the Biotechnology industry
Industry Median: 189.69 vs BNTX: 252.61

BioNTech SE's Days Inventory increased from Dec. 2022 (177.81) to Dec. 2023 (194.76). It might indicate that BioNTech SE's sales slowed down.

Warning Sign:

If a company builds up inventory, it may mean it is having difficulties selling its goods.

Inventory Turnover measures how fast the company turns over its inventory within a year. BioNTech SE's Inventory Turnover for the three months ended in Dec. 2023 was 0.47.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. BioNTech SE's Inventory-to-Revenue for the three months ended in Dec. 2023 was 0.26.

BioNTech SE Days Inventory Historical Data

The historical data trend for BioNTech SE's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNTech SE Days Inventory Chart

BioNTech SE Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Inventory

Get a 7-Day Free Trial

185.11

230.22

35.82

59.45

238.77

BioNTech SE Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Inventory	Get a 7-Day Free Trial															177.81	408.27	243.11	245.72	194.76

Competitive Comparison of BioNTech SE's Days Inventory

For the Biotechnology subindustry, BioNTech SE's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioNTech SE's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioNTech SE's Days Inventory distribution charts can be found below:

* The bar in red indicates where BioNTech SE's Days Inventory falls into.

BioNTech SE Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

BioNTech SE's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

	Days Inventory (A: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (465.678	+	390.076)	/	2 )	/	654.089	*	365
=	427.877					/	654.089	*	365
=	238.77

BioNTech SE's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

	Days Inventory (Q: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Sep. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (443.65	+	390.076)	/	2 )	/	195.311	*	365 / 4
=	416.863					/	195.311	*	365 / 4
=	194.76

BioNTech SE (NAS:BNTX) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

BioNTech SE's Inventory Turnover for the three months ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	195.311	/	416.863
	=	0.47

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

BioNTech SE's Inventory to Revenue for the three months ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	416.863	/	1612.868
	=	0.26

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

BioNTech SE Days Inventory Related Terms

Thank you for viewing the detailed overview of BioNTech SE's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

BioNTech SE (BioNTech SE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioNTech SE (NAS:BNTX) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

BNTX:Mexico 0A3M:UK 22UA:Germany B1NT34:Brazil BNTX:Austria

Address

An der Goldgrube 12, Mainz, RP, DEU, D-55131

Website

https://www.biontech.de

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. COVID-19 vaccine Comirnaty is its first commercialized product.